Form 4: BioCardia CEO Acquires 1,350 Shares in Open Market Transaction

BioCardia's President and CEO, Peter Altman, purchased 1,350 shares of common stock at $1.87 per share on November 15, 2024.

Summary

• Peter Altman, President and CEO of BioCardia, Inc., acquired 1,350 shares of the company's common stock.
• The transaction occurred on November 15, 2024, at a price of $1.87 per share.
• Following this transaction, Mr. Altman directly owns 105,331 shares of BioCardia common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive as the CEO's purchase could be seen as a sign of confidence, but it's a small transaction and not a major market signal.

Positives

• The CEO's purchase of shares may indicate confidence in the company's future prospects.

Industry Context

This is a routine filing related to insider trading and is common for publicly traded companies. It does not indicate any specific trend in the industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading activity.
• There are no specific industry benchmarks to compare this transaction to, as it is an individual executive's purchase of shares.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

BioCardia, Peter Altman, stock purchase, insider trading, common stock, executive, share acquisition